Literature DB >> 19225236

Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study.

Breno Satler Diniz1, Paula Villela Nunes, Mônica Sanches Yassuda, Orestes Vicente Forlenza.   

Abstract

BACKGROUND/AIMS: The diagnostic stability of mild cognitive impairment (MCI) on short-term follow-up is a key issue in the characterization of this clinical syndrome. We aim to determine the cognitive outcome after 1 year of follow-up in a cohort of older adults.
METHODS: Baseline clinical and neuropsychological assessments were carried out in older subjects recruited at a tertiary memory clinic. The subjects were reassessed after 1 year of follow-up with the same clinical and neuropsychological protocol.
RESULTS: A total of 115 older adults, including MCI (n = 54) and controls (n = 61), underwent baseline and follow-up evaluation. Ten subjects classified as MCI at baseline (23%) resumed normal cognitive function and 13 controls (21%) progressed to MCI upon follow-up (chi(2) = 0.015, d.f. = 1, p = 0.90). The subjects diagnosed as having MCI on both assessments were older (p = 0.002) and had a worse global cognitive performance according to the Cambridge Cognitive Test (p = 0.014).
CONCLUSION: The subjects who maintain the MCI status are older and have a worse baseline cognitive performance as well as multiple cognitive deficits. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19225236     DOI: 10.1159/000203346

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  12 in total

1.  Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.

Authors:  Yane Guo; Zengqiang Zhang; Bo Zhou; Pan Wang; Hongxiang Yao; Minshao Yuan; Ningyu An; Haitao Dai; Luning Wang; Xi Zhang; Yong Liu
Journal:  Neurosci Bull       Date:  2014-04-23       Impact factor: 5.203

Review 2.  Should mild cognitive impairment be subtyped?

Authors:  Tiffany F Hughes; Beth E Snitz; Mary Ganguli
Journal:  Curr Opin Psychiatry       Date:  2011-05       Impact factor: 4.741

3.  Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly.

Authors:  Rodolfo B Ladeira; Breno S Diniz; Paula V Nunes; Orestes V Forlenza
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

4.  Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.

Authors:  Breno Satler Diniz; Charles F Reynolds; Amy Begley; Mary Amanda Dew; Stewart J Anderson; Francis Lotrich; Kirk I Erickson; Oscar Lopez; Howard Aizenstein; Etienne L Sibille; Meryl A Butters
Journal:  J Psychiatr Res       Date:  2013-11-20       Impact factor: 4.791

5.  MEG spectral analysis in subtypes of mild cognitive impairment.

Authors:  M E López; P Cuesta; P Garcés; P N Castellanos; S Aurtenetxe; R Bajo; A Marcos; M L Delgado; P Montejo; J L López-Pantoja; F Maestú; A Fernandez
Journal:  Age (Dordr)       Date:  2014-02-16

6.  Memory and Executive Screening (MES): a brief cognitive test for detecting mild cognitive impairment.

Authors:  Qi-hao Guo; Bin Zhou; Qian-hua Zhao; Bei Wang; Zhen Hong
Journal:  BMC Neurol       Date:  2012-10-11       Impact factor: 2.474

7.  Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study.

Authors:  Perminder S Sachdev; Darren M Lipnicki; John Crawford; Simone Reppermund; Nicole A Kochan; Julian N Trollor; Wei Wen; Brian Draper; Melissa J Slavin; Kristan Kang; Ora Lux; Karen A Mather; Henry Brodaty
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

Review 8.  Diagnosis and biomarkers of predementia in Alzheimer's disease.

Authors:  Orestes V Forlenza; Breno S Diniz; Wagner F Gattaz
Journal:  BMC Med       Date:  2010-12-22       Impact factor: 8.775

9.  Machine Learning-based Individual Assessment of Cortical Atrophy Pattern in Alzheimer's Disease Spectrum: Development of the Classifier and Longitudinal Evaluation.

Authors:  Jin San Lee; Changsoo Kim; Jeong-Hyeon Shin; Hanna Cho; Dae-Seock Shin; Nakyoung Kim; Hee Jin Kim; Yeshin Kim; Samuel N Lockhart; Duk L Na; Sang Won Seo; Joon-Kyung Seong
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

10.  Early diagnosis and treatment of Alzheimer's disease: new definitions and challenges.

Authors:  Marcos Pais; Luana Martinez; Octávio Ribeiro; Júlia Loureiro; Romel Fernandez; Leandro Valiengo; Paulo Canineu; Florindo Stella; Leda Talib; Marcia Radanovic; Orestes V Forlenza
Journal:  Braz J Psychiatry       Date:  2020-01-24       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.